Response to Crudele et al. Commentary on Mayock et al. “In Vitro Drug Release after Crushing: Evaluation of Xtampza(®) ER and Other ER Opioid Formulations”

Detalles Bibliográficos
Autores principales: Fleming, Alison B., Mayock, Stephen P., Saim, Said
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061363/
https://www.ncbi.nlm.nih.gov/pubmed/29949104
http://dx.doi.org/10.1007/s40261-018-0664-y
_version_ 1783342208569573376
author Fleming, Alison B.
Mayock, Stephen P.
Saim, Said
author_facet Fleming, Alison B.
Mayock, Stephen P.
Saim, Said
author_sort Fleming, Alison B.
collection PubMed
description
format Online
Article
Text
id pubmed-6061363
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-60613632018-08-09 Response to Crudele et al. Commentary on Mayock et al. “In Vitro Drug Release after Crushing: Evaluation of Xtampza(®) ER and Other ER Opioid Formulations” Fleming, Alison B. Mayock, Stephen P. Saim, Said Clin Drug Investig Letter to the Editor Springer International Publishing 2018-06-12 2018 /pmc/articles/PMC6061363/ /pubmed/29949104 http://dx.doi.org/10.1007/s40261-018-0664-y Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Letter to the Editor
Fleming, Alison B.
Mayock, Stephen P.
Saim, Said
Response to Crudele et al. Commentary on Mayock et al. “In Vitro Drug Release after Crushing: Evaluation of Xtampza(®) ER and Other ER Opioid Formulations”
title Response to Crudele et al. Commentary on Mayock et al. “In Vitro Drug Release after Crushing: Evaluation of Xtampza(®) ER and Other ER Opioid Formulations”
title_full Response to Crudele et al. Commentary on Mayock et al. “In Vitro Drug Release after Crushing: Evaluation of Xtampza(®) ER and Other ER Opioid Formulations”
title_fullStr Response to Crudele et al. Commentary on Mayock et al. “In Vitro Drug Release after Crushing: Evaluation of Xtampza(®) ER and Other ER Opioid Formulations”
title_full_unstemmed Response to Crudele et al. Commentary on Mayock et al. “In Vitro Drug Release after Crushing: Evaluation of Xtampza(®) ER and Other ER Opioid Formulations”
title_short Response to Crudele et al. Commentary on Mayock et al. “In Vitro Drug Release after Crushing: Evaluation of Xtampza(®) ER and Other ER Opioid Formulations”
title_sort response to crudele et al. commentary on mayock et al. “in vitro drug release after crushing: evaluation of xtampza(®) er and other er opioid formulations”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061363/
https://www.ncbi.nlm.nih.gov/pubmed/29949104
http://dx.doi.org/10.1007/s40261-018-0664-y
work_keys_str_mv AT flemingalisonb responsetocrudeleetalcommentaryonmayocketalinvitrodrugreleaseaftercrushingevaluationofxtampzaerandothereropioidformulations
AT mayockstephenp responsetocrudeleetalcommentaryonmayocketalinvitrodrugreleaseaftercrushingevaluationofxtampzaerandothereropioidformulations
AT saimsaid responsetocrudeleetalcommentaryonmayocketalinvitrodrugreleaseaftercrushingevaluationofxtampzaerandothereropioidformulations

Ejemplares similares